GlassScriptPhysician profile
Fernando Diaz
NPI 1619920832
$1,990.41
in general payments reported to CMS, 2019-2025
7 companies · $195 in 2025
The $195 reported for 2025 was more than what 80% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $204 · 2021: $83.25 · 2022: $39.97 · 2023: $1,403 · 2024: $64.89 · 2025: $195.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $837 · Food and Beverage: $826.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $837.20 |
| Food and Beverage | $825.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $1,347.42 | 2021-2024 | Hemosphere |
| Abbott Laboratories | $181.47 | 2019-2023 | Mitraclip |
| Abiomed | $170.13 | 2024-2025 | Impella |
| Abbvie INC. | $125.00 | 2019 | |
| Getinge USA Sales, LLC | $112.13 | 2022-2023 | Cardioroot |
| Cvrx, INC. | $30.82 | 2025 | Barostim Neo System |
| Pacira Pharmaceuticals Incorporated | $23.44 | 2025 | Exparel |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Fernando Diaz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.